Physician profile
Brian Pierson
NPI 1922368596
$1,137.97
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $880 · 2020: $35.01 · 2021: $73.98 · 2023: $98.36 · 2024: $51.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $325.64 | 2019-2023 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $250.06 | 2019-2023 | Abilify Maintena |
| Alkermes, INC. | $163.80 | 2019-2023 | Aristada, Lybalvi |
| Allergan, INC. | $115.55 | 2019 | |
| Sunovion Pharmaceuticals INC. | $100.58 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.88 | 2023-2024 | Caplyta |
| Vanda Pharmaceuticals INC. | $35.52 | 2019 | |
| Brainsway USA INC | $32.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $31.86 | 2021 | |
| Indivior INC. | $19.71 | 2024 | Perseris |
| Lundbeck LLC | $15.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Pierson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.